New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
06:09 EDTSGYPSynergy Pharmaceuticals to start second phase 3 clinical trial for plecanatide
Synergy Pharmaceuticals announced the start of its second pivotal phase 3 clinical trial to confirm the safety and efficacy of plecanatide, its lead uroguanylin analog and once-daily oral treatment, in adult patients with chronic idiopathic constipation, or CIC. This phase 3 trial is a randomized, double-blind clinical trial to compare a 12-week, dose-ranging regimen of plecanatide against placebo in adult patients with CIC.
News For SGYP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
09:16 EDTSGYPOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTSGYPSynergy Pharm says analysis shows Phase 2 SP-333 trial met primary endpoint
Subscribe for More Information
November 10, 2014
16:30 EDTSGYPGreat Point Partners reports 6.35% passive stake in Synergy Pharmaceuticals
16:11 EDTSGYPSynergy Pharmaceuticals reports Q3 EPS (24c), consensus (28c)
Synergy's cash, cash equivalents and available-for-sale securities balance as of September 30 was $32.7M as compared to $68.1M on December 31, 2013.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use